Zevra Therapeutics Inc. (ZVRA) — Long-term Investment Intensity

Latest as of September 2025: 11.4%

Zevra Therapeutics Inc. (ZVRA) has a Long-term Investment Intensity of 11.4% as of September 2025. Long-term investments of $30.86 Million represent 11.4% of total assets of $270.12 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ZVRA book value for net asset value and shareholders' equity analysis.

LT Investment Intensity

11.4%
LT Investments / Total Assets

Long-term Investments

$30.86 Million
USD

Total Assets

$270.12 Million
USD

Country

USA
NASDAQ

Zevra Therapeutics Inc. Long-term Investment Intensity (2021–2024)

This chart shows how Zevra Therapeutics Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2021 to 2024. As of September 2025, the intensity stands at 11.4%, reflecting long-term investments of $30.86 Million against total assets of $270.12 Million USD. Also explore Zevra Therapeutics Inc. (ZVRA) total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Zevra Therapeutics Inc. (2021–2024)

The table below presents the year-by-year Long-term Investment Intensity for Zevra Therapeutics Inc. from 2021 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ZVRA stock market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2024 3.4% $6.01 Million $178.13 Million ▼ -14.0 pp
2022 17.3% $20.00 Million $115.34 Million ▲ +5.7 pp
2021 11.6% $15.42 Million $132.94 Million
pp = percentage points